Please login to the form below

Not currently logged in

UK clears NHS use of Gilead’s remdesivir for COVID-19 patients


MHRA approved the drug under the Early Access to Medicines Scheme

Merck buys Themis as part of drive for COVID-19 drugs and vaccines

Merck & Co HQDeal also adds a pipeline of vaccines for other infectious diseases as well as cancer

New data backs remdesivir for COVID-19, but rings hydroxychloroquine alarm bell

GileadRemdesivir could speed recovery of patients with COVID-19, but hydroxychloroquine may not be safe

FDA backs BMS’ Opdivo/Yervoy in first-line NSCLC

BMS buildingFinally wins approval in market dominated by rival Keytruda

CEPI-backed coronavirus vaccine from Novavax starts trials

Coronavirus vaccineNVX-CoV2373 is tenth vaccine to reach human testing stage

Q&A: Elizabeth Egan

Elizabeth Egan is President of Havas Lynx Group

The Gallery

A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – to add your work to The Gallery please contact us.

War games: why brand teams need a cunning plan that cannot fail

Chris Ross turns to a military metaphor – and the wisdom of battle-hardened experts – to explore how pharma can overcome the challenges of strategic planning

Alzheimer’s: the search for a cure

Will Biogen’s aducanumab re-energise the hunt for pharma’s white whale?

Alzheimer's trees

Innovation in the time of coronavirus

The Distancer is a simple, handheld device that aims to help ensure the safety of key workers

3D Life Prints Distancer

McCann Health France strengthens team with two new hires

Melissa Brunet and Christelle David-Basei join the agency

Melissa Brunet

Preparing for online interviews and remote working

As the world changes to social distancing, here are some pointers for employees to think about

COVID-19 Updates and Daily News

Featured jobs


Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

COVID-19: the race to find a vaccine
How biopharma is working to bring an end to the pandemic...
Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy
Global product lead George Kirk hails the triumph of selumetinib, which has just won FDA approval...
The art of delivering valuable customer journeys aligned to your key messages in 2020...